One-share investing that might change the world ~ A World Tour with One-Share Walker ~From the era of reading DNA to the era ...

AmplexDiagnostics and Scope Biosciences are proud to introduce a groundbreaking solution in molecular diagnostics. In a new ...

All good things must come to an end. Sadly, Homo sapiens’ time on Earth is no exception. And someone would surely take our ...

More than 250 million people carry hepatitis B virus, and roughly a million die from it each year. The drugs we have suppress the virus but ...

Base editing reached human trials, but the FDA's April 2026 NGS safety draft guidance reveals how far the regulatory ...

This year, ASHG is pleased to recognize seven recipients of its 2026 Professional Awards for their outstanding achievements in human genetics and genomics research, education, mentorship, and public ...

Nabsys 2.0, LLC ("Nabsys") today announced the release of RepX™, a repeat expansion analysis pipeline available through its Nabsys Navigator™ cloud platform. RepX uses Electronic Genome Mapping (EGM) ...

Spread the love“`html Imagine a world where doctors can pinpoint the exact cause of a mysterious illness, not in weeks or months, but in days, sometimes even hours. A world where elusive infections, ...

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center used a CRISPR screen to identify a key molecular pathway that drives exhaustion in cancer-fighting immune cells, limiting their ...

One of the main ways that the APOE4 gene variant, the biggest genetic risk factor for late-onset Alzheimer's disease, ...

A WashU Medicine project to develop an injectable treatment to reverse tissue damage in osteoarthritis has received $17 ...

Scribe Therapeutics is initiated with a buy rating, targeting the in-vivo gene therapy market for cardiometabolic diseases.